EXACTUS, INC. (OTCMKTS:EXDI) Files An 8-K Regulation FD Disclosure
Regulation FD Disclosure
On January 17, we released the press release furnished herewith as Exhibit 99.1.
Section 9 – FINANCIAL STATEMENTS AND EXHIBITS
Financial Statements and Exhibits
Exactus, Inc. Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE exhibit 99.1 Exhibit 99.1 Exactus Inc. Announces Entry into Hemp CBD Market Enters into Supply and Development Agreement with Ceed2Med,…
To view the full exhibit click
About EXACTUS, INC. (OTCMKTS:EXDI)
Exactus, Inc. (Exactus), formerly Spiral Energy Tech, Inc., is a life science company. The Company will develop and commercialize Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a detection platform. The Company’s primary business focus will be the development and commercialization of the FibriLyzer and related technology licensed by Exactus. The Company’s products will employ a disposable test biosensor strip combined with a portable hand held detection unit that provides a result in approximately 30 seconds. The Company intends to file to gain regulatory approval and launch its products in the United States and Europe.